PMDA drug package insert
カルバゾクロムスルホン酸Na錠30mg「あすか」
PMDA Prescription drug · あすか製薬株式会社 · package insert Jan 24, 2024
Key facts
| Brand names | カルバゾクロムスルホン酸Na錠30mg「あすか」 |
|---|---|
| Nonproprietary names | カルバゾクロムスルホン酸ナトリウム水和物 |
| Companies | 製造販売元／あすか製薬株式会社, 発売元／千寿製薬株式会社, 販売元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 対血管薬剤 |
| Therapeutic category codes | 873321 |
| YJ codes | 3321002F2455 |
| Approval numbers | 30100AMX00316 |
| Package insert edition | 第1版 |
| Package insert date | Jan 24, 2024 |
| PMDA document key | 470007_3321002F2455_2 |
| PMDA company code | 470007 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: